Layer3.news

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxzgd3kggzjhjg7r9cmdmtmdkjvl3dhvag96gutdfzs8qs4qwst0qta2y92

MILLIONS MORE AMERICANS COULD ACCESS OBESITY DRUGS AFTER TRUMP'S DEALS WITH ELI LILLY, NOVO NORDISK

https://image.cnbcfm.com/api/v1/image/108222507-1762449574908-gettyimages-2244837799-AFP_83AZ29H.jpeg?v=1762449648&w=1920&h=1080

✍️ US President Donald Trump announces landmark deals with Eli Lilly and Novo Nordisk to expand access to costly obesity drugs, with Medicare covering GLP-1s for certain patients starting in mid-2026.

👉 Medicare will cover GLP-1s for certain patients starting in mid-2026 👉 Eli Lilly and Novo Nordisk will lower prices for state Medicaid programs 👉 Direct-to-consumer offerings will provide discounts on obesity drugs 👉 Private insurers are expected to follow suit and expand coverage

-- #DonaldTrump #DavidRicks #NickFabrizio #DariusLakdawalla #ChrisSchott #Washington,DC #WhiteHouse #health

Loading quoted post…

Donald Trump David Ricks Nick Fabrizio Darius Lakdawalla Chris Schott Washington, DC White House health

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqgmt0myqcc4d4jfj7urdtcx08602f0exvugdkujueecxj2qa4s67st2x9fr

NOVO NORDISK, LILLY SHARES SLIP ON US DRUG PRICING DEAL

https://media.zenfs.com/en/reuters.com/ef7892fbf77e9074babac0df1e82d8d0

✍️ Novo Nordisk and Eli Lilly agreed to lower prices of their GLP-1 weight-loss drugs for US government programs and cash payers, reducing monthly prices to between $149 and $350.

👉 Novo Nordisk and Eli Lilly agreed to lower prices of their GLP-1 weight-loss drugs 👉 Monthly prices will be reduced to between $149 and $350 for US government programs and cash payers 👉 Novo expects bigger volumes under Medicare in the mid to long-term 👉 Lilly's CEO said the price cut represents a 20-35% discount compared to diabetes drug Mounjaro

-- #JacobGronholt-Pedersen #MaggieFick #DavidRicks #MarkusManns #MikeDoustdar #KevinGade #Copenhagen #UnitedStates #health

Loading quoted post…

Jacob Gronholt-Pedersen Maggie Fick David Ricks Markus Manns Mike Doustdar Kevin Gade Copenhagen United States

nostr:nevent1qvzqqqqqqypzqen9mck95fvwtvf7n9wgneuudfgpsvcr6t6nh0pct9rfzvh4ulzsqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqucyvysvhwjhdhh64yqlu5lc4ycvrnufpkttzx50qp526kwl3wmkqj6kv6s

npub1vejautz…gdp57w

SUSTO IN THE WHITE HOUSE: A HIGH-RANKING EXECUTIVE FROM A LABORATORY FAINTED DURING A TRUMP CONFERENCE IN THE OVAL OFFICE

https://www.clarin.com/img/2025/11/07/LcpZhOodH_2000x1500__1.jpg

✍️ A man fainted during a press conference by US President Donald Trump in the Oval Office, causing a brief interruption.

👉 A man fainted during a press conference by US President Donald Trump 👉 The incident occurred in the Oval Office 👉 Trump and others rushed to the man's aid 👉 The press was temporarily removed from the room 👉 The man was reportedly receiving medical attention but was later said to be fine

-- #DonaldTrump #DavidRicks #MehmetOz #KarolineLeavitt #GordonFindlay #OvalOffice #CasaBlanca #politics

Loading quoted post…

Donald Trump David Ricks Mehmet Oz Karoline Leavitt Gordon Findlay Oval Office Casa Blanca politics

nostr:nevent1qvzqqqqqqypzpc24fcukpkr60sl9kkzy7w9qy34s0vrayd773fkt0ax2dg3rsx4mqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq73zlhmq22kj83kjnh977mh8wpa6fzxg5pq7f7lg5s2mwg354xzqssz0un7

npub1u925uwt…77hudd

DR. OZ LEAPS INTO ACTION WHEN PHARMA EXEC FAINTS IN OVAL OFFICE

https://media.breitbart.com/media/2025/11/Oval-Office-Dr.-Oz-640x335.jpg

✍️ Dr. Mehmet Oz rushed to help a pharmaceutical executive who passed out during a White House press conference on expanding coverage for obesity medications.

👉 Dr. Oz helped a pharmaceutical executive who passed out during a White House press conference 👉 The executive, Gordon Findlay, appeared to be faint and Oz rushed to catch him before he dropped to the floor 👉 Oz helped Findlay to the ground and ensured his safety before the press conference resumed 👉 The incident occurred while drugmakers Eli Lilly and Novo Nordisk were announcing a deal with the Trump administration on expanding coverage and reducing prices for obesity medications

-- #Dr.MehmetOz #GordonFindlay #PresidentDonaldTrump #RobertF.KennedyJr. #DavidRicks #KarolineLeavitt #OliviaRondeau #PhilomenaOz #WhiteHouse #OvalOffice #politics

Loading quoted post…

Dr. Mehmet Oz Gordon Findlay President Donald Trump Robert F. Kennedy Jr.David Ricks Karoline Leavitt Olivia Rondeau Philomena Oz

nostr:nevent1qvzqqqqqqypzqjmytcahp0hwmk3vr0xhuuqegpsjyghjy858der555g379pcd5vgqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqcf9qdp8au370xexa2stw2zwvr9m93u7hfxyxf5vk9n92dv6nm65qkj7se0

A PHARMACEUTICAL EXECUTIVE FAINTED DURING A TRUMP CONFERENCE

https://resizer.glanacion.com/resizer/v2/76XZMX5JUZBYHJEKWYXN57HKVM.png?auth=6ed0d47bc979ad14f4ec76e7c28048caa06f930f1e609196e1c8a9ec8eadb3d8&smart=true&width=893&height=820

✍️ Novo Nordisk executive Gordon Findlay fainted during a press conference at the White House, interrupting an announcement about reducing prices of popular weight-loss medications.

👉 Novo Nordisk executive Gordon Findlay fainted during a press conference at the White House 👉 The conference was announcing a deal between the US government and pharmaceutical companies Eli Lilly and Novo Nordisk 👉 The agreement aims to reduce prices of popular weight-loss medications 👉 The medications will be made more accessible to Medicare and Medicaid recipients 👉 The US administration has been pushing pharmaceutical companies to reduce prices under the 'nation most favored' policy

-- #GordonFindlay #DonaldTrump #DavidRicks #RobertF.KennedyJr. #WhiteHouse #health

Loading quoted post…

Gordon Findlay Donald Trump David Ricks Robert F. Kennedy Jr.White House health Argentina:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4n0jzytrm8esqg5zztjvuacu6lyt2lee5gcewpp4lxyvp8engz5s73jrfl

TRUMP ANNOUNCES DEALS WITH ELI LILLY, NOVO NORDISK TO SLASH WEIGHT LOSS DRUG PRICES, OFFER SOME MEDICARE COVERAGE

https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080

✍️ The Trump administration has announced deals with Eli Lilly and Novo Nordisk to slash the prices of some obesity drugs, including upcoming pills, and expand access to Medicare and Medicaid beneficiaries.

👉 Eli Lilly and Novo Nordisk will cut prices of GLP-1 drugs for Medicare and Medicaid beneficiaries in 2026 👉 The treatments will be offered directly to consumers at a discount on TrumpRx.gov 👉 Medicare will start covering obesity drugs for some patients for the first time, starting mid-2026 👉 The deals are part of the Trump administration's push to rein in high U.S. drug costs

-- #DonaldTrump #DavidRicks #MikeDoustdar #JoeBiden #health

Loading quoted post…

Donald Trump David Ricks Mike Doustdar Joe Biden health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqgeqeanmmusy9e7tuu08nkh9fpt2ur05zq24dcp2qa2a08s55phsq027nae

ELI LILLY (LLY) WOULD BE UP MORE IF THE MARKET WEREN’T THAT BAD, SAYS JIM CRAMER

https://media.zenfs.com/en/insidermonkey.com/ff8020a547cc353e36a06eaa2c1811e3

✍️ Jim Cramer praises Eli Lilly and Company's weight loss drugs and manufacturing plans, but notes that the stock needs catalysts for further gains.

👉 Jim Cramer praises Eli Lilly and Company's weight loss drugs 👉 Cramer notes that the company's plans to establish a robust manufacturing process in America are positive 👉 Cramer believes that the company's third-quarter results and guidance hike are positive signs 👉 Cramer admits that the firm needs some catalysts for the shares to make further gains

-- #JimCramer #DavidRicks #business

Loading quoted post…

Jim Cramer David Ricks business mainstream:perspective

11/1/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqfm2t24c4zeeqqt0hxlrukwqdt5v2k2du79lqqq8nrhr57tdkmydslkn36l

3 TAKEAWAYS FOR INVESTORS TRACKING EXECUTIVE INSIDER TRADES

https://s.yimg.com/ny/api/res/1.2/Mc7m14BdybOQkP8C0y.xwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/quartz_855/753ee6e4ddd8ac2e72e2496d60f9d682

✍️ Insiders at major Fortune 500 companies, including Nvidia, Tesla, and Fox Corp., have been selling significant amounts of stock, with some executives buying back shares after a market decline.

👉 Insiders at major Fortune 500 companies have been selling significant amounts of stock 👉 Some executives are buying back shares after a market decline 👉 Three factors to consider when analyzing insider trades: mindset, trade being unique to the insider, and buying might signal a genuine trend 👉 Insider selling may not always be a good indicator of a company's performance 👉 Insider buying can signal a genuine trend and provide valuable insights for investors

-- #JensenHuang #DavidRicks #PaulHolmes #OlivierWagner #DavidMiller #MattWoodley #business

Loading quoted post…

Jensen Huang David Ricks Paul Holmes Olivier Wagner David Miller Matt Woodley business mainstream:perspective

10/21/2025

nostr:nevent1qvzqqqqqqypzqjmytcahp0hwmk3vr0xhuuqegpsjyghjy858der555g379pcd5vgqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4895u4x4lj0xc5866u6erqxpd3y3qsfa2dkqem82xnppg5mdmt8q0h86hx

LABS IN THE CROSSHAIRS: TRUMP'S OFFENSE AGAINST 'ABUSIVE' DRUG PRICES

https://resizer.glanacion.com/resizer/v2/R2DUKPVLO5BU5EKGRWMMIPU5ZI.png?auth=b352ac7fbd6c0aa6d1049e748378cc53330933fa7ad2440126e06f8601d02024&smart=true&width=2000&height=1333

✍️ The pharmaceutical industry is facing pressure from US President Donald Trump to lower drug prices, with a new website offering discounted medications and a proposal to tie prices to the lowest in other rich countries.

👉 President Trump's proposal to tie drug prices to the lowest in other rich countries 👉 The pharmaceutical industry's concerns about the impact on innovation and access to new medications 👉 Some companies already offering discounted medications 👉 The FDA may get involved in the negotiations

-- #DonaldTrump #DavidRicks #PascalSoriot #PeterKolchinsky #MartyMakary #DariusLakdawalla #UnitedStates #Europe #China #India #ReinoUnido #health

Loading quoted post…

Donald Trump David Ricks Pascal Soriot Peter Kolchinsky Marty Makary Darius Lakdawalla United States Europe

10/4/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdv77a3y7pwu6298see5jguc6x8ksnd84g2v5awc93hl2k6qc3yvsamz6jr

LILLY TO BUILD $6.5B HOUSTON FACTORY FOR ITS FIRST OBESITY PILL

https://s.yimg.com/ny/api/res/1.2/CATXB0uHPdESoB58WgenTQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/manufacturing_dive_692/07fa929717374d9bee4e1e35f6ab3300

✍️ Eli Lilly is building a $6.5 billion factory in Houston to manufacture its first obesity pill and other small molecule medicines, creating 615 full-time jobs.

👉 Eli Lilly is building a $6.5 billion factory in Houston to manufacture its first obesity pill and other small molecule medicines. 👉 The facility will produce active pharmaceutical ingredients, including orforglipron, a small, oral GLP-1 receptor agonist. 👉 The project is part of Lilly's pledge to bolster domestic medicine production. 👉 The facility will create 615 full-time jobs, including engineers, scientists, and lab technicians. 👉 The company has committed to investing more than $50 billion to construct and refurbish its U.S. factories.

-- #DavidRicks #Houston #GenerationPark #GoochlandCounty #Richmond #Virginia #Texas #Indiana #NorthCarolina #NewJersey #Wisconsin #PuertoRico #business

Loading quoted post…

David Ricks Houston Generation Park Goochland County Richmond Virginia Texas Indiana

9/25/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2xnd0qnu5kxehjc4q6w096a72nxz68fve8yy8y0jp6ujv9n7f06qy2ussg

ELI LILLY TO BUILD $6.5BN ORFORGLIPRON PRODUCTION SITE IN TEXAS

https://media.zenfs.com/en/pharmaceutical_technology_376/45c4320b83276a7201a9550d2ec2e593

✍️ Eli Lilly is building a $6.5 billion active pharmaceutical product (API) facility in Texas, US, to produce its small molecule therapeutics, including orforglipron, a potential treatment for obesity and type 2 diabetes.

👉 Eli Lilly is building a $6.5 billion API facility in Texas, US 👉 The facility will produce Eli Lilly's small molecule therapeutics, including orforglipron 👉 Orforglipron is a potential treatment for obesity and type 2 diabetes 👉 The facility will create 615 engineering, scientific, and operational jobs 👉 The facility will begin producing medicines within five years

-- #DavidRicks #DonaldTrump #Texas #Virginia #Austin #LakeHouston #GoochlandCounty #health

Loading quoted post…

David Ricks Donald Trump Texas Virginia Austin Lake Houston Goochland County health

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqlteluc608u7s807pcdnpk0fu4umt3m6fut3uvqdry5f4pxvl08rqsrxghs

LILLY TO INVEST $6.5BN IN API MANUFACTURING FACILITY IN TEXAS

https://s.yimg.com/ny/api/res/1.2/lX349uUogC6p1RQ8cAppUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/pharmaceutical_technology_376/d3106aa7614535d61874dba5b6221a17

✍️ Eli Lilly and Company plans to invest $6.5bn in an API manufacturing facility in Houston, Texas, creating 615 permanent jobs and generating 4,000 jobs during the construction phase.

👉 Eli Lilly and Company plans to invest $6.5bn in an API manufacturing facility in Houston, Texas 👉 The facility will create 615 permanent jobs and generate 4,000 jobs during the construction phase 👉 The facility will produce APIs for small-molecule medicines, including those targeting oncology, cardiometabolic health, immunology, and neuroscience 👉 Lilly plans to implement advanced technologies, including AI, machine learning, and digital automation

-- #DavidRicks #Houston #Texas #GenerationPark #GoochlandCounty #Virginia #business

Loading quoted post…

David Ricks Houston Texas Generation Park Goochland County Virginia business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs0futyzj3r9gy0s0w8f5kpjlk42ukf9nyqgchr2f9evc429vc97qfyn8he

ELI LILLY TO BUILD $6.5 BILLION TEXAS MANUFACTURING FACILITY FOR OBESITY PILL, OTHER DRUGS

https://image.cnbcfm.com/api/v1/image/108202857-1758645145595-Savage_Rendering.jpg?v=1758645286&w=1920&h=1080

✍️ Eli Lilly to spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of small molecule drugs, including its experimental obesity pill.

👉 Eli Lilly to spend $6.5 billion to build a manufacturing facility in Houston, Texas 👉 Facility will focus on manufacturing orforglipron and small molecule medicines across different disease areas 👉 New facility will bring 615 jobs to the Greater Houston area and 4,000 construction jobs 👉 Part of Eli Lilly's plan to boost domestic production and reduce reliance on imported pharmaceuticals

-- #DavidRicks #DonaldTrump #Houston,Texas #UnitedStates #business

Loading quoted post…

David Ricks Donald Trump Houston, Texas United States business mainstream:perspective

9/23/2025

npub17r26x6s…qehva5

ELI LILLY’S OBESITY PILL OUTPERFORMS NOVO NORDISK’S ORAL DRUG IN HEAD-TO-HEAD DIABETES TRIAL

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1758079235&w=1920&h=1080

✍️ Eli Lilly's experimental pill outperformed Novo Nordisk's oral drug in a head-to-head study for Type 2 diabetes patients, with better blood sugar control and weight loss.

👉 Eli Lilly's pill outperformed Novo Nordisk's oral drug in a head-to-head study for Type 2 diabetes patients 👉 Better blood sugar control and weight loss were achieved with Eli Lilly's pill 👉 The pill helped patients lose an average of 9.2% of their weight, compared to 5.3% with Novo Nordisk's pill 👉 Eli Lilly's pill may be a more effective treatment option for Type 2 diabetes patients, particularly those with obesity

-- #DanSkovronsky #HowardWeintraub #DavidRicks #JaimeAlmandoz #Indianapolis #NewYork #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpux45d4p4xur8cxzhn5qa70dnwrgl0mu4xmsvvwy2de3hefumppfqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq55a9sdwscju0enrjuy5msqwkzuz8u07498d4h9vxt6pgnah9aqyqnjpfug

Dan Skovronsky Howard Weintraub David Ricks Jaime Almandoz Indianapolis New York health mainstream:perspective

9/17/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5z99hp3pdj5uut5z6ulzsw34s0ar3tg8qvs7h5ql3r7vlaz0dphq83anq7

ELI LILLY TO INVEST $5 BILLION IN NEW VIRGINIA PLANT AS PHARMA BRACES FOR TARIFFS

https://media.zenfs.com/en/reuters-finance.com/501f23f2f11af58b00af165222c16992

✍️ Eli Lilly to invest $5 billion in a new manufacturing facility in Virginia, expanding domestic production and hedging against potential tariffs.

👉 Eli Lilly to invest $5 billion in a new manufacturing facility in Virginia 👉 Facility will produce active pharmaceutical ingredients for cancer, autoimmune, and other advanced therapies 👉 Will expand company's capacity to make antibody-drug conjugates, a targeted class of cancer treatments 👉 Plant expected to be completed within five years 👉 Will create over 650 jobs for skilled workers and 1,800 construction jobs

-- #DavidRicks #Virginia #GoochlandCounty #business

Loading quoted post…

David Ricks Virginia Goochland County business mainstream:perspective

9/16/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjwlgn7wlvsxju94manemt6r7h6ms0p6u2gq9x6yett5f43ytqg8swr3vj3

JIM CRAMER URGES PATIENCE WITH ELI LILLY AND COMPANY (LLY)’S STOCK

https://s.yimg.com/ny/api/res/1.2/jpFqt3OWj5BLfvymCRKwqA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NDE-/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347

✍️ Jim Cramer discusses Eli Lilly and Company's latest weight loss drug trial, praising CEO David Ricks and the company's potential.

👉 Eli Lilly and Company's weight loss drug trial showed promising results 👉 CEO David Ricks praised for his leadership and vision 👉 Company has a lot more in the pipeline 👉 New trial's results are a 'gigantic win'

-- #JimCramer #DavidRicks #business

Loading quoted post…

Jim Cramer David Ricks business mainstream:perspective

9/3/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxd894clzhedm2ylu0m5k9jeue797jmdygajec3ne8dnm8p9jkwzs6h94k2

ELI LILLY'S OBESITY PILL REMAINS A VIABLE RIVAL TO NOVO'S ORAL WEGOVY DESPITE DATA THAT UNDERWHELMED INVESTORS

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1755834451&w=1920&h=1080

✍️ Eli Lilly's obesity pill, orforglipron, underwhelmed Wall Street with its trial data, causing less weight loss and higher side effects than expected. Despite this, analysts believe it could still be a viable competitor in the weight loss drug market.

👉 Eli Lilly's orforglipron pill caused less weight loss and had higher side effects than expected in a late-stage trial. 👉 Analysts believe orforglipron could still be a viable competitor in the weight loss drug market. 👉 Novo Nordisk's oral semaglutide showed strong data in a separate study, but Eli Lilly's pill could still have advantages over it. 👉 Eli Lilly's pill is absorbed more easily in the body and doesn't require dietary restrictions like Novo Nordisk's pill. 👉 Eli Lilly's pill could have a lower price point than Novo Nordisk's pill.

-- #DavidRicks #Mihail'Misha'Zilbermint #MikeDoustar #EvanSeigerman #DavidRisinger #JaredHolz #Indianapolis #Copenhagen #Bagsvaerd #health

Loading quoted post…

David Ricks Mihail 'Misha' Zilbermint Mike Doustar Evan Seigerman David Risinger Jared Holz Indianapolis Copenhagen

8/24/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqnrk4gf3hsh0ps9c0hc6du3547hmq4pd0xtdh9qjhmgxq0l7vhm6qz0nmh3

NOVO NORDISK SOARS AFTER 50% OZEMPIC DISCOUNT, LIVER TREATMENT APPROVAL

https://s.yimg.com/ny/api/res/1.2/jpFHBMxg5hOUgTkB5UNRdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://media.zenfs.com/en/the_daily_upside_435/c54e2274e57e079ff0abfa24cf7e8bdb

✍️ Novo Nordisk announces a discount on its diabetes drug Ozempic for cash-paying customers in the US, priced at $499 per month, in an effort to defend its market share against competitors.

👉 Novo Nordisk announces a discount on Ozempic for cash-paying customers in the US, priced at $499 per month 👉 The move is seen as a response to pressure from President Donald Trump and a bipartisan pushback in Washington over high prices 👉 Novo Nordisk's decision to halve the price of Ozempic is seen as a crowning achievement 👉 The company faces competition from cheaper copycat drugs and a rival, Eli Lilly, which has been gaining market share

-- #DonaldTrump #DavidRicks #KansasCity #Washington #business

Loading quoted post…

Donald Trump David Ricks Kansas City Washington business mainstream:perspective

8/20/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqkaquc7s2knk8f2xu7vety2n0fv4n3gwdtlycpx6un2wxzvgdmlvsfxa4h9

LLY: ELI LILLY STOCK TANKS -- INSIDERS RUSH IN WITH MILLIONS

https://media.zenfs.com/en/us.finance.gurufocus/6ada8bac43bee8fbae1bb1b3966ea10f

✍️ Eli Lilly insiders, including CEO David Ricks and Chief Scientific Officer Dan Skovronsky, purchased shares after a 14% drop in the company's stock price due to disappointing trial results.

👉 Eli Lilly's shares fell 14% after disappointing interim data from the Phase 3 ATTAIN-1 trial 👉 Insiders, including CEO David Ricks and Chief Scientific Officer Dan Skovronsky, purchased shares 👉 Analysts are divided on the stock's potential, with some seeing the dip as a buying opportunity and others warning that upside is limited until clearer trial data arrive

-- #DavidRicks #DanSkovronsky #GabrielleSulzberger #ErikFrywald #IlyaYuffa #business

Loading quoted post…

David Ricks Dan Skovronsky Gabrielle Sulzberger Erik Frywald Ilya Yuffa business mainstream:perspective

8/13/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqw4vz98pzj8xedfy0ryj5kjvvrw4kcja05l52kze4e4panq3kf4nqefgseh

WHY NOVO NORDISK STOCK FLEW HIGHER ON FRIDAY

https://s.yimg.com/ny/api/res/1.2/Qi4SdZuUKVDKJ9Xr9lj8iA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/3e0f8f08e4f3e742a6f73072a0aa4245

✍️ Novo Nordisk's stock price rose nearly 5% on Friday after Eli Lilly's investigational obesity drug, orforglipron, showed less impressive results in a clinical study compared to Novo Nordisk's Wegovy.

👉 Eli Lilly's orforglipron showed an average weight loss of nearly 12% in a 72-week study 👉 The results fell short of analysts' expectations of 15% 👉 Novo Nordisk's stock price rose nearly 5% on Friday 👉 Eli Lilly's CEO, David Ricks, expressed optimism about the results

-- #DavidRicks #business

Loading quoted post…

8/10/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqzyp0ukjjv02ra54glpmxmz0r72k88vmm9wyynf7amh427dpq4yhqm8t24t

ELI LILLY WEIGHT-LOSS PILL TRIAL DISAPPOINTS, OFFSETTING SOLID PROFIT AND SALES

https://s.yimg.com/ny/api/res/1.2/27kZavsE_Tgojw0QZGVJzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/investopedia_245/26e590b53b7beaa8077e62e187b83ecc

✍️ Eli Lilly's experimental weight loss pill, orforglipron, showed disappointing results in a late-stage trial, with average weight loss below that of rival Novo Nordisk's Wegovy.

👉 Eli Lilly's experimental weight loss pill, orforglipron, showed disappointing results in a late-stage trial. 👉 The pill showed an average weight loss of 12.4% in a 72-week period, below the 15% average weight loss of Novo Nordisk's Wegovy. 👉 Lilly's CEO argued that the results met the company's goals. 👉 The news offset Lilly's strong quarterly results and guidance boost. 👉 Lilly raised its full-year adjusted EPS range to $21.75 to $23.00, compared to the earlier estimate of $20.78 to $22.28.

-- #DavidRicks #business

Loading quoted post…

8/8/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq63z42qckun7t87q8fxhlkcmzvyf4lwt0my2n4afdmlsdgwcvdapqjgcaw7

THIS BLUE-CHIP STOCK IS COOKING UP A MAJOR GROWTH CATALYST

https://s.yimg.com/ny/api/res/1.2/P2m_8PEC7iGRb8sIC7LPGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03Nzk-/https://media.zenfs.com/en/barchart_com_477/5f81f612d4b225905cde3fd6dfce2095

✍️ Eli Lilly and Company's diabetes medication, Mounjaro, has shown promising results in a landmark study, demonstrating cardiovascular benefits comparable to traditional heart medications. This breakthrough could expand Mounjaro's prescribing potential and accelerate the company's momentum.

👉 Eli Lilly's Mounjaro shows cardiovascular benefits comparable to traditional heart medications 👉 Mounjaro achieves primary objective by proving it was not inferior to Trulicity 👉 Patients taking Mounjaro had a 16% lower mortality rate compared to those on Trulicity 👉 Patients on Mounjaro had an 8% lower risk of cardiovascular death, heart attack, or stroke 👉 Mounjaro's results could expand its prescribing potential and accelerate Eli Lilly's momentum 👉 Eli Lilly aims to submit heart health data to global regulators by year-end and plans to present study at a medical conference in September

-- #DavidRicks #JaredHolz #Dr.DavidBroome #KenCuster #health

Loading quoted post…

David Ricks Jared Holz Dr. David Broome Ken Custer health mainstream:perspective

8/7/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqpm8uejg49f5h7aq555p6g63jydl9wxls336ev24uejucx774zc2sdq5crs

THE 3 THINGS THAT MATTER FOR ELI LILLY NOW

https://s.yimg.com/ny/api/res/1.2/OjD73lQ1C5m3EiV_1z5UQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4ec62ad0158497cb622542747ccc1bed

✍️ Eli Lilly's stock performance has been impacted by a slowdown this year, but the company's prospects remain strong, driven by its oral GLP-1 candidate tirzepatide and its pipeline of other candidates.

👉 Tirzepatide's sales growth and potential label expansions 👉 Orglipron's phase 3 results in weight management 👉 Eli Lilly's valuation and potential for a sell-off if results disappoint

-- #DavidRicks #business

Loading quoted post…

7/24/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrm2nhck7pg6dje3w5ua4d4tz873fnxcmqpm3y22slx0lyxa3svqsjtzllm

ELI LILLY AND COMPANY (LLY): I WOULD “LOVE” IF TRUMP PRAISED THE COMPANY, SAYS JIM CRAMER

https://s.yimg.com/ny/api/res/1.2/UjoPACeXPFyN.4G.yM_TTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3

✍️ Jim Cramer discusses Eli Lilly and Company (NYSE:LLY) as a potential investment opportunity, citing its lead in the weight loss drug market and pipeline of drugs targeting diseases such as hypertension.

👉 Eli Lilly and Company (NYSE:LLY) is a leading player in the weight loss drug market 👉 The company is expanding its manufacturing base 👉 Eli Lilly and Company (NYSE:LLY) has a strong pipeline of drugs targeting diseases such as hypertension 👉 Jim Cramer believes the company will benefit from introducing a weight loss pill

-- #JimCramer #DavidRicks #KenLangone #RFKJr. #business

Loading quoted post…

Jim Cramer David Ricks Ken Langone RFK Jr.business mainstream:perspective

7/12/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxny6cptfxhnc4ac6t9he35lx5q4vu6pw6xt7gpmavagvg5fn2w4qsjt5m9

ANALYSIS-NOVO NORDISK SHOULD LOOK TO THE US FOR ITS NEXT CEO, ANALYSTS SAY

https://media.zenfs.com/en/reuters-finance.com/a35c1b481cd59ba9e90b8b6e2993ec4f

✍️ Novo Nordisk is searching for a new CEO to replace Lars Fruergaard Jorgensen, and analysts suggest an American leader could be better suited to navigate the company's largest market, the US, amidst the Trump administration's changes to pharmaceutical trade, manufacturing, and regulation.

👉 Novo Nordisk is searching for a new CEO 👉 Analysts suggest an American leader could be better suited to navigate the company's largest market, the US 👉 The Trump administration is rewriting the rules on pharmaceutical trade, manufacturing, and regulation 👉 Novo Nordisk has struggled against US rival Eli Lilly 👉 The company needs someone who understands the US system better

-- #LarsFruergaardJorgensen #LarsRebienSorensen #MadsOvlisen #DavidMoore #DonaldTrump #DavidRicks #EvanSeigerman #AlexAzar #Denmark #UnitedStates #London #NewYork #Indyansapolis #business

Loading quoted post…

Lars Fruergaard Jorgensen Lars Rebien Sorensen Mads Ovlisen David Moore Donald Trump David Ricks Evan Seigerman Alex Azar

5/17/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqzrdw35cedffgfztya4vh6njdkgh9ac8aekgjlny3m0ctjpr6yelsrnaqcf

DOWN NEARLY 20%: SHOULD YOU BUY THE DIP ON ELI LILLY?

https://s.yimg.com/ny/api/res/1.2/RkAifZVs2u3WF6cBAUVPQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d5878469cb97eb1c273d6fd5d5520396

✍️ Eli Lilly's share price has declined due to earnings misses and increased competition, but the company's growth prospects still look promising.

👉 Earnings misses and increased competition in the obesity drug market have contributed to Lilly's share price decline 👉 Lilly's growth prospects still look promising, with sales booming for its tirzepatide products 👉 The company has a strong pipeline of obesity drugs, including orforglipron and olomorasib 👉 The CEO has acknowledged the potential negative impact of tariffs and Medicare pricing changes 👉 Lilly's dominance in the obesity and type 2 diabetes markets is expected to continue

-- #DavidRicks #business

Loading quoted post…

5/9/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2t0qmsqejdxnzqv93e6v9t8ft4kj08mpkfd0v5gy9lv3730llqsq7uj8lz

TRUMP IS THREATENING BIG PHARMA WITH TARIFFS. TAX CHANGES MIGHT WORK BETTER.

https://s.yimg.com/ny/api/res/1.2/Ysn2ZnFwMizyKsrmwzxwfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/4f2301aba414d3f6169ce056b9c6b76c

✍️ President Trump's tariffs may not bring back industries that rely on cheap labor, but changes to the tax code could encourage long-term investment in the US.

👉 The pharmaceutical industry still retains a significant base of production in the US, particularly for high-value medicines. 👉 Tariffs may prompt some companies to stockpile imports and expand production within existing US sites. 👉 Changes to the tax code could play a more crucial role in long-term investment in the US. 👉 The US corporate rate was lowered to 21% in 2017, and Ireland raised its headline rate to 15%. 👉 Pharma CEOs are pushing for further changes to the tax code, including a 15% tax rate for US manufacturing and restoring full expensing for capital investments.

-- #DavidRicks #ChristineKachinsky #GeorgeCallas #BradSetser #MartaWosińska #PaulRyan #DonaldTrump #Ireland #Pennsylvania #Ohio #Europe #China #India #business

Loading quoted post…

David Ricks Christine Kachinsky George Callas Brad Setser Marta Wosińska Paul Ryan Donald Trump Ireland

5/8/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqec4099u8ckx4xw6zxem8s7cm975mkpargeyvq7rrntthnugmeg3syndgmw

WITH COMPOUNDERS OUT OF THE WAY, LILLY AND NOVO GO AFTER EACH OTHER

https://s.yimg.com/ny/api/res/1.2/gt2AJjJlIUQApjs9IbltKQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/pharma_voice_330/c1ac62ef819bc147c6612404328d2b78

✍️ GLP-1 rivals Eli Lilly and Novo Nordisk are engaged in a battle for market dominance in the obesity space, with Lilly now holding a 53% share of the market.

👉 Lilly now holds a 53% share of the GLP-1 market, overtaking Novo for the first time. 👉 Novo's Wegovy will be the preferred drug of CVS Caremark's standard formulary starting July 1. 👉 Both companies are expanding their direct-to-consumer platforms, new indications, and next-generation GLP-1s to gain market share. 👉 Lilly's tirzepatide medication brought in $2.3 billion during the quarter. 👉 Novo is gunning to get ahead of Lilly in the oral GLP-1 market, and last month filed for an approval of its obesity pill.

-- #DavidRicks #PatrickJonsson #PremShah #health

Loading quoted post…

David Ricks Patrick Jonsson Prem Shah health mainstream:perspective

5/5/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqkjng2zgd3ksfrahuf9j8m9nvah8w9uxa6pwxqstarh5auyuukazs9mpe7j

WHAT IS CVS? 'WE ARE ... WORKING THROUGH THAT VERY QUESTION'

https://s.yimg.com/ny/api/res/1.2/6dtG3NDISSb.oCs8l_0qew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-05/5ea5d9c0-26bc-11f0-8f6b-dc6b742f3b22

✍️ CVS Health's CEO David Joyner is working to define the company's identity and strategy, as it faces challenges in its retail pharmacy business and questions about its ability to succeed in the health provider space.

👉 CVS Health's retail pharmacy business has been struggling for years 👉 The company's pharmacy benefit manager Caremark is facing political pressure 👉 CVS's ability to succeed in the health provider space with its 2023 acquisition of Oak Street is uncertain 👉 CEO David Joyner is working to define the company's identity and strategy 👉 CVS wants to become America's most trusted healthcare company

-- #DavidJoyner #KarenLynch #DavidRicks #health

Loading quoted post…

David Joyner Karen Lynch David Ricks health mainstream:perspective

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjcvhp7tqr7hfhgf2ldxzanq67y3c25a7gu4tjg95d6ppx8cmtwpqd9x3py

ELI LILLY STOCK SELL-OFF WAS 'OVERREACTION': ANALYSTS

https://s.yimg.com/ny/api/res/1.2/rIzohBB.wriHeI88c5Mh.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-05/c68a4b50-2759-11f0-bbfe-08549428ce43

✍️ Eli Lilly's stock plummeted 12% after Novo Nordisk secured a preferred listing deal with CVS for its obesity drug Wegovy, excluding Eli Lilly's Zepbound.

👉 Eli Lilly's stock lost 12% after Novo Nordisk secured a preferred listing deal with CVS for its obesity drug Wegovy 👉 Novo Nordisk's deal with CVS excludes Eli Lilly's Zepbound 👉 Analysts believe the market reaction was overdone and that the impact on Eli Lilly's sales will be limited 👉 The deal is seen as a key reason why Novo Nordisk's stock has been declining

-- #DavidRisinger #AkashTewari #TimAnderson #DavidRicks #AnjaleeKhemlani #business

Loading quoted post…

David Risinger Akash Tewari Tim Anderson David Ricks Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt50pmjg60h5kpv7dq54nslxl9hu52ssqzygwrkqaqglg204l0qeq7ug4j0

LOWER TAXES COULD BRING MORE DRUG PRODUCTION TO U.S., SAYS ELI LILLY

https://images.wsj.net/im-34062673/social

✍️ Eli Lilly CEO David Ricks suggests that lower taxes could bring more drug production back to the US, citing the potential for permanent low tax rates.

👉 Eli Lilly CEO suggests lower taxes could bring more drug production back to the US 👉 Permanent low tax rates, such as 15% for domestic production, could be a significant incentive 👉 CEO emphasizes the importance of 'carrots' over 'sticks' in encouraging businesses

-- #DavidRicks #US #business

Loading quoted post…

David Ricks US business mainstream:perspective

5/2/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvuvxcaznuf6v7d6qz3rza4d70ad9fcyspdj737ax097zfmdg3trq9jvlmt

ELI LILLY STOCK SLIPS DESPITE EARNINGS BEAT, REAFFIRMED 2025 GUIDANCE

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported strong first-quarter earnings, beating expectations, but GLP-1 sales were modestly ahead of consensus.

👉 Eli Lilly reported strong first-quarter earnings 👉 GLP-1 sales were modestly ahead of consensus 👉 Company's stock was trading down nearly 5% in pre-market trading 👉 Lilly CEO David Ricks expressed confidence in the company's pipeline and focus on the next generation of drugs

-- #DavidRicks #AnjaleeKhemlani #business

Loading quoted post…

David Ricks Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvwgxaqxevgp29phvlm42ye347t3yvz3h2dp9qt8n39z7vzanw7dsyjw45l

TRUMP HINTS AT TARIFF REPRIEVE FOR PHARMA FIRMS WHO BRING OPERATIONS BACK TO US

https://i.guim.co.uk/img/media/af40329f336707b11e7c2065b035c5a14e180eec/0_257_3085_1852/master/3085.jpg?width=140&quality=85&auto=format&fit=max&s=9220b86c25c7f98a3ee4c67e3c213d7d

✍️ Donald Trump hints at a tariff reprieve for pharmaceutical companies, offering them 'a lot of time' to move operations to the US before facing import taxes.

👉 Pharma companies may face fresh sector-specific import taxes as early as next week 👉 Trump offers 'a lot of time' for companies to move operations to the US before facing levies 👉 Companies that move operations to the US would face no tariffs 👉 Trump hints at a reprieve or pause on punitive tariffs on semiconductors

-- #DonaldTrump #DavidRicks #JoaquinDuato #AppleCEO(notspecified) #WhiteHouse #Ireland #US #politics

Loading quoted post…

Donald Trump David Ricks Joaquin Duato Apple CEO (not specified)White House Ireland US politics

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7ucjzhtr3md45kvwtejy238mzkmf6382k9zn0lf3rlnrg8xulw2qdajtak

JIM CRAMER CALLS ELI LILLY AND COMPANY (LLY) A ‘GAME CHANGER’ AFTER OBESITY PILL TRIAL SUCCESS

https://media.zenfs.com/en/insidermonkey.com/b59e3def8f182d3e4f871bfc8cc254fe

✍️ Jim Cramer discusses the possibility of President Trump firing the chairman of the Federal Reserve, Jerome Powell, and its potential impact on the stock market.

👉 Jim Cramer discusses the possibility of President Trump firing the chairman of the Federal Reserve, Jerome Powell 👉 Cramer links this possibility to the recent dismissals of officials from the Federal Trade Commission 👉 Cramer believes that the potential action against Powell might have been priced into the markets 👉 Cramer discusses the results of a weight loss pill trial for Eli Lilly and Company (NYSE:LLY) 👉 Cramer believes that Eli Lilly and Company (NYSE:LLY) is a strong stock with a moat

-- #JimCramer #JeromePowell #DavidRicks #MelissaRivers #PeggyNewton #CNBC #FederalReserve #FederalTradeCommission #NorthCarolina #politics

Loading quoted post…

Jim Cramer Jerome Powell David Ricks Melissa Rivers Peggy Newton CNBC Federal Reserve Federal Trade Commission

4/25/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqtg6yz7k66ylyfxfu3z3tyyta58qtlrjmwtnvkczjsyy8s66xzncsdvakxz

INTUITIVE SURGICAL DIVES. THE IMPACT FROM TARIFFS 'COULD BE MATERIAL.'

https://www.investors.com/wp-content/uploads/2019/01/stock-Intuitive-Surgical-04-shutter.jpg

✍️ Intuitive Surgical's stock plummeted after the company warned that President Trump's tariffs could have a 'material' impact on its financials this year.

👉 Intuitive Surgical's stock plunged over 5% to $451 👉 The company expects its gross profit margin to decrease due to tariffs 👉 Additional tariffs could have a significant impact on the company's financial results 👉 The company's guidance for procedure volume growth was raised 👉 Intuitive Surgical's CEO warned that tariffs could have a 'material' impact on the company's financials

-- #DonaldTrump #JoaquinDuato #DavidRicks #TravisSteed #AllisonGatlin #UnitedStates #China #Sunnyvale,California #business

Loading quoted post…

Donald Trump Joaquin Duato David Ricks Travis Steed Allison Gatlin United States China Sunnyvale, California

4/24/2025

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqm2m4sm6stkg2m7jtnqcjrszqr6rk88hwt9xkm25k4ggcy3qvmxls7rtnt2

NEW DAILY WEIGHT-LOSS PILL SHOWS SUCCESS AT CLINICAL TRIAL

https://i.guim.co.uk/img/media/305b35a980ce76ca7cc6787ec59c291cad49285f/0_111_3355_2014/master/3355.jpg?width=140&quality=85&auto=format&fit=max&s=89362cc06f17783a14374b5b227b926c

✍️ A daily weight-loss pill, orforglipron, has been found to help people shed pounds and reduce blood sugar levels, making it a contender to combat obesity and diabetes.

👉 The trial found that orforglipron helped people lose an average of 7.3kg over nine months. 👉 The pill reduced blood sugar levels, in some cases bringing them below the formal threshold for diabetes. 👉 The trial met expectations on safety, tolerability, glucose control, and weight loss. 👉 The results suggest that daily pill versions of the medicine could allow more people to control their weight and blood sugar levels.

-- #DavidRicks #NaveedSattar #US #China #India #Japan #Mexico #Britain #Glasgow #health

Loading quoted post…

David Ricks Naveed Sattar US China India Japan Mexico Britain

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrfkmwhx7g3ljnm45wc2p76j9x42avf7qd2p2gqq4h7476ldxxl7quphwqd

ELI LILLY'S WEIGHT LOSS PILL SUCCEEDS IN FIRST LATE-STAGE TRIAL ON DIABETES PATIENTS

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1744850495&w=1920&h=1080

✍️ Eli Lilly's daily obesity pill, orforglipron, met the company's goals in a late-stage trial, helping Type 2 diabetes patients lower their blood sugar and body weight, and showing safety on par with popular injections.

👉 Eli Lilly's daily obesity pill, orforglipron, met the company's goals in a late-stage trial 👉 The pill helped Type 2 diabetes patients lower their blood sugar and body weight 👉 The pill showed safety and tolerability similar to popular injections on the market 👉 The pill could help more patients access treatments and alleviate supply shortfalls of popular injections

-- #DavidRicks #Indianapolis,Indiana #health

Loading quoted post…

David Ricks Indianapolis, Indiana health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjsxvqsydllrffzvj8c0auttfvhvq3q6fksv39usje70uucnwkmsq70qce5

DOW JONES, S&P 500 PHARMA NAMES RECOVER AFTER TRUMP BACKS OFF HIS TARIFFS PLAN

https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg

✍️ President Trump's announcement of major tariffs on drug imports caused a brief shock in the pharmaceutical industry, but he later delayed the tariffs for 90 days, leading to a recovery in pharma stocks.

👉 President Trump announced major tariffs on drug imports 👉 Pharma stocks initially dropped in response 👉 Trump later delayed the tariffs for 90 days 👉 Analysts and company executives expressed concerns about the impact of tariffs on the industry 👉 Some companies announced plans to invest in US manufacturing

-- #DonaldTrump #MarieThibault #DavidRisinger #DavidRicks #JohnAdent #BrandonVazquez #China #US #Europe #business

Loading quoted post…

Donald Trump Marie Thibault David Risinger David Ricks John Adent Brandon Vazquez China US

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2f00rqu28j2cu7law2l6uy0cz3ycwy6ch47q30nvxqxp4g0f2qzqxnacdl

JIM CRAMER ON ELI LILLY AND COMPANY (LLY): “YOU DON’T SELL LILLY” — “DAVID RICKS IS A VISIONARY”

https://media.zenfs.com/en/insidermonkey.com/dc5a2bcb6b4c16a43cb5b4ba98feb139

✍️ Jim Cramer discusses Eli Lilly and Company's (NYSE:LLY) performance and expresses support for the company's CEO and stock.

👉 Eli Lilly and Company's (NYSE:LLY) performance discussed on Mad Money 👉 Jim Cramer expresses frustration over tariff policies 👉 Company's strong pipeline and growth outlook highlighted 👉 Shares have recovered and risen 7% since Cramer's call

-- #JimCramer #JamesSurowiecki #DavidRicks #PresidentTrump #Frankfurt,Germany #business

Loading quoted post…

Jim Cramer James Surowiecki David Ricks President Trump Frankfurt, Germany business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq673kjpn408rcryv33l0g0lkk3avgkevp268uvynecjuam6qdtn2s65hhhk

ELI LILLY CEO DAVID RICKS JUST DELIVERED TERRIBLE NEWS TO INVESTORS: SHOULD YOU SELL THE STOCK?

https://media.zenfs.com/en/motleyfool.com/561b84a0dfa536aa800055cdc5065456

✍️ Eli Lilly's CEO, David Ricks, expressed concerns about the potential impact of tariffs on the pharmaceutical industry, but the company's strong innovation and manufacturing capabilities make it a resilient investment.

👉 Tariffs could increase prices for consumers and affect the pharmaceutical industry 👉 Eli Lilly's CEO, David Ricks, is concerned about the potential impact of tariffs 👉 The company is building new manufacturing facilities in the US to avoid tariffs 👉 Eli Lilly has a strong pipeline of new drugs and is well-positioned to handle the potential impact of tariffs

-- #DavidRicks #UnitedStates #Europe #London #business

Loading quoted post…

David Ricks United States Europe London business mainstream:perspective

4/9/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdmjldkxzyu2tpcynwv36ye484d42af2779yw4mnj0z7dc4fnqmyq99dl5u

CEOS SOUND OFF ON THE RETURN-TO-OFFICE WARS: ‘I’M THE ONLY PERSON IN THE OFFICE, AND IT’S DRIVING ME NUTS’

https://s.yimg.com/ny/api/res/1.2/ETBZxnWZGC5LX7wdi9BSWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/fortune_175/86a785ad03de6a05142c0d32d8c31f38

✍️ CEOs from various industries share their strategies for attracting and retaining talent in a tight labor market, citing factors such as career opportunities, hybrid work arrangements, and upskilling.

👉 60% of people leave companies due to lack of career opportunities 👉 Only 10% of open roles are filled by internal candidates 👉 Hybrid work arrangements can be an effective tool for attracting and retaining talent 👉 Upskilling and reskilling are key drivers for employee development 👉 The 'great resignation' is becoming the 'great stay' as quit rates fall

-- #SharonMarcil #PeggyJohnson #ThierryDelaporte #DorisMeister #MariaBlack #JudyMarks #RohitKapoor #DavidRicks #JohnSchlifske #AlanMurray #U.S. #BayArea #business

Loading quoted post…

Sharon Marcil Peggy Johnson Thierry Delaporte Doris Meister Maria Black Judy Marks Rohit Kapoor David Ricks

2/3/2025

npub125q6jmq…n7fd7f

PRES. TRUMP AND RFK JR. MEET BIG PHARMA EXECUTIVES FROM PFIZER AND ELI LILLY AT MAR-A-LAGO: REPORT

https://www.thegatewaypundit.com/wp-content/uploads/2024/08/rfk-jr-kennedy-jr.-trump-e1724600494957-1200x630.jpg

✍️ Robert Kennedy Jr. endorses Donald Trump for President in 2024, citing Trump's commitment to making America healthy again and ending the chronic disease epidemic.

👉 Pfizer CEO Albert Bourla, Lilly CEO David Ricks, and PhRMA CEO Steve Ubl attended a meeting with Trump and Kennedy at Mar-a-Lago 👉 Trump has asked Kennedy to clean up corruption in government health agencies, return those agencies to evidence-based science, and make America healthy again 👉 Kennedy has been critical of the pharmaceutical industry's influence on public health policies 👉 Trump has promised to make America healthy again and end the chronic disease epidemic

-- #RobertKennedyJr. #DonaldTrump #AlbertBourla #DavidRicks #SteveUbl #SusieWiles #JoeBiden #JimHoft #Mar-a-Lago #politics

Loading quoted post…

nostr:nevent1qvzqqqqqqypzq4gp49kp3rkunahg9her00mqa9zt5tpznk4wkq95cyxf0rhzcl3nqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2q0m2g6ttsksrw2fdax72p3glwynjpxv06u9ferg6v9m7hyn5hzs42v6pw

Robert Kennedy Jr.Donald Trump Albert Bourla David Ricks Steve Ubl Susie Wiles Joe Biden Jim Hoft

12/5/2024

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqus4ny5mv7vky7j0w2x0wk59exwc8vcfkrfzgcvtj2c5cn3j4pjwqz57tyt

THE WEIGHT-LOSS FRENZY IS MAKING SOME PHARMA STOCKS MUCH MORE VOLATILE. WILL THE DRAMA CONTINUE?

https://s.yimg.com/os/creatr-uploaded-images/2024-10/9fb131b0-a2f2-11ef-a6bc-956076f696c8

✍️ The recent volatility in GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market, which is expected to be a $150 billion market by the end of the decade.

👉 The weight loss market is expected to be a $150 billion market by the end of the decade. 👉 Any financial miss or negative data will trigger outsized sell-offs in GLP-1 stocks. 👉 Leading companies in the GLP-1 space, such as Amgen and Eli Lilly, have seen significant losses due to missed analyst estimates and negative data. 👉 The potential for high returns has created an energy around the leading GLP-1 companies.

-- #DavidRicks #GeoffMeacham #PeterGriffith #JaredHolz #ChrisShibutani #JaredBlikre #AnjaleeKhemlani #mainstream #health

Loading quoted post…

David Ricks Geoff Meacham Peter Griffith Jared Holz Chris Shibutani Jared Blikre Anjalee Khemlani mainstream

11/16/2024

Layer3.news

AI by layer3.news

Filtering by: David Ricks · clear filter

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqyfvurv2k5gcm3j7dl4lheputk68gqt69qxugv0eettcghdfe29qqmtm2fx

JIM CRAMER COMMENTS ON ELI LILLY (LLY)’S SHARES AFTER PFIZER CEO’S REMARKS

https://s.yimg.com/ny/api/res/1.2/rn.PoO4Nt4R4QI7Ku7ho5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/insidermonkey.com/cb218414709808bf2f63f98ca522d436

✍️ Jim Cramer discussed Eli Lilly and Company (NYSE:LLY) on CNBC, citing its manufacturing investments, weight loss pill, and drug portfolio as reasons for optimism.

-- #JimCramer #DavidRicks #PfizerCEO,Dr.Bourla #business

Loading quoted post…

Jim Cramer David Ricks Pfizer CEO, Dr. Bourla business mainstream:perspective

11/18/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxzgd3kggzjhjg7r9cmdmtmdkjvl3dhvag96gutdfzs8qs4qwst0qta2y92

MILLIONS MORE AMERICANS COULD ACCESS OBESITY DRUGS AFTER TRUMP'S DEALS WITH ELI LILLY, NOVO NORDISK

https://image.cnbcfm.com/api/v1/image/108222507-1762449574908-gettyimages-2244837799-AFP_83AZ29H.jpeg?v=1762449648&w=1920&h=1080

✍️ US President Donald Trump announces landmark deals with Eli Lilly and Novo Nordisk to expand access to costly obesity drugs, with Medicare covering GLP-1s for certain patients starting in mid-2026.

-- #DonaldTrump #DavidRicks #NickFabrizio #DariusLakdawalla #ChrisSchott #Washington,DC #WhiteHouse #health

Loading quoted post…

Donald Trump David Ricks Nick Fabrizio Darius Lakdawalla Chris Schott Washington, DC White House health

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqgmt0myqcc4d4jfj7urdtcx08602f0exvugdkujueecxj2qa4s67st2x9fr

NOVO NORDISK, LILLY SHARES SLIP ON US DRUG PRICING DEAL

https://media.zenfs.com/en/reuters.com/ef7892fbf77e9074babac0df1e82d8d0

✍️ Novo Nordisk and Eli Lilly agreed to lower prices of their GLP-1 weight-loss drugs for US government programs and cash payers, reducing monthly prices to between $149 and $350.

-- #JacobGronholt-Pedersen #MaggieFick #DavidRicks #MarkusManns #MikeDoustdar #KevinGade #Copenhagen #UnitedStates #health

Loading quoted post…

Jacob Gronholt-Pedersen Maggie Fick David Ricks Markus Manns Mike Doustdar Kevin Gade Copenhagen United States

nostr:nevent1qvzqqqqqqypzqen9mck95fvwtvf7n9wgneuudfgpsvcr6t6nh0pct9rfzvh4ulzsqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqucyvysvhwjhdhh64yqlu5lc4ycvrnufpkttzx50qp526kwl3wmkqj6kv6s

npub1vejautz…gdp57w

SUSTO IN THE WHITE HOUSE: A HIGH-RANKING EXECUTIVE FROM A LABORATORY FAINTED DURING A TRUMP CONFERENCE IN THE OVAL OFFICE

https://www.clarin.com/img/2025/11/07/LcpZhOodH_2000x1500__1.jpg

✍️ A man fainted during a press conference by US President Donald Trump in the Oval Office, causing a brief interruption.

-- #DonaldTrump #DavidRicks #MehmetOz #KarolineLeavitt #GordonFindlay #OvalOffice #CasaBlanca #politics

Loading quoted post…

Donald Trump David Ricks Mehmet Oz Karoline Leavitt Gordon Findlay Oval Office Casa Blanca politics

nostr:nevent1qvzqqqqqqypzpc24fcukpkr60sl9kkzy7w9qy34s0vrayd773fkt0ax2dg3rsx4mqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq73zlhmq22kj83kjnh977mh8wpa6fzxg5pq7f7lg5s2mwg354xzqssz0un7

npub1u925uwt…77hudd

DR. OZ LEAPS INTO ACTION WHEN PHARMA EXEC FAINTS IN OVAL OFFICE

https://media.breitbart.com/media/2025/11/Oval-Office-Dr.-Oz-640x335.jpg

✍️ Dr. Mehmet Oz rushed to help a pharmaceutical executive who passed out during a White House press conference on expanding coverage for obesity medications.

-- #Dr.MehmetOz #GordonFindlay #PresidentDonaldTrump #RobertF.KennedyJr. #DavidRicks #KarolineLeavitt #OliviaRondeau #PhilomenaOz #WhiteHouse #OvalOffice #politics

Loading quoted post…

Dr. Mehmet Oz Gordon Findlay President Donald Trump Robert F. Kennedy Jr.David Ricks Karoline Leavitt Olivia Rondeau Philomena Oz

nostr:nevent1qvzqqqqqqypzqjmytcahp0hwmk3vr0xhuuqegpsjyghjy858der555g379pcd5vgqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqcf9qdp8au370xexa2stw2zwvr9m93u7hfxyxf5vk9n92dv6nm65qkj7se0

A PHARMACEUTICAL EXECUTIVE FAINTED DURING A TRUMP CONFERENCE

https://resizer.glanacion.com/resizer/v2/76XZMX5JUZBYHJEKWYXN57HKVM.png?auth=6ed0d47bc979ad14f4ec76e7c28048caa06f930f1e609196e1c8a9ec8eadb3d8&smart=true&width=893&height=820

✍️ Novo Nordisk executive Gordon Findlay fainted during a press conference at the White House, interrupting an announcement about reducing prices of popular weight-loss medications.

-- #GordonFindlay #DonaldTrump #DavidRicks #RobertF.KennedyJr. #WhiteHouse #health

Loading quoted post…

Gordon Findlay Donald Trump David Ricks Robert F. Kennedy Jr.White House health Argentina:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4n0jzytrm8esqg5zztjvuacu6lyt2lee5gcewpp4lxyvp8engz5s73jrfl

TRUMP ANNOUNCES DEALS WITH ELI LILLY, NOVO NORDISK TO SLASH WEIGHT LOSS DRUG PRICES, OFFER SOME MEDICARE COVERAGE

https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080

✍️ The Trump administration has announced deals with Eli Lilly and Novo Nordisk to slash the prices of some obesity drugs, including upcoming pills, and expand access to Medicare and Medicaid beneficiaries.

-- #DonaldTrump #DavidRicks #MikeDoustdar #JoeBiden #health

Loading quoted post…

Donald Trump David Ricks Mike Doustdar Joe Biden health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqgeqeanmmusy9e7tuu08nkh9fpt2ur05zq24dcp2qa2a08s55phsq027nae

ELI LILLY (LLY) WOULD BE UP MORE IF THE MARKET WEREN’T THAT BAD, SAYS JIM CRAMER

https://media.zenfs.com/en/insidermonkey.com/ff8020a547cc353e36a06eaa2c1811e3

✍️ Jim Cramer praises Eli Lilly and Company's weight loss drugs and manufacturing plans, but notes that the stock needs catalysts for further gains.

-- #JimCramer #DavidRicks #business

Loading quoted post…

Jim Cramer David Ricks business mainstream:perspective

11/1/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqfm2t24c4zeeqqt0hxlrukwqdt5v2k2du79lqqq8nrhr57tdkmydslkn36l

3 TAKEAWAYS FOR INVESTORS TRACKING EXECUTIVE INSIDER TRADES

https://s.yimg.com/ny/api/res/1.2/Mc7m14BdybOQkP8C0y.xwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/quartz_855/753ee6e4ddd8ac2e72e2496d60f9d682

✍️ Insiders at major Fortune 500 companies, including Nvidia, Tesla, and Fox Corp., have been selling significant amounts of stock, with some executives buying back shares after a market decline.

-- #JensenHuang #DavidRicks #PaulHolmes #OlivierWagner #DavidMiller #MattWoodley #business

Loading quoted post…

Jensen Huang David Ricks Paul Holmes Olivier Wagner David Miller Matt Woodley business mainstream:perspective

10/21/2025

nostr:nevent1qvzqqqqqqypzqjmytcahp0hwmk3vr0xhuuqegpsjyghjy858der555g379pcd5vgqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq4895u4x4lj0xc5866u6erqxpd3y3qsfa2dkqem82xnppg5mdmt8q0h86hx

LABS IN THE CROSSHAIRS: TRUMP'S OFFENSE AGAINST 'ABUSIVE' DRUG PRICES

https://resizer.glanacion.com/resizer/v2/R2DUKPVLO5BU5EKGRWMMIPU5ZI.png?auth=b352ac7fbd6c0aa6d1049e748378cc53330933fa7ad2440126e06f8601d02024&smart=true&width=2000&height=1333

✍️ The pharmaceutical industry is facing pressure from US President Donald Trump to lower drug prices, with a new website offering discounted medications and a proposal to tie prices to the lowest in other rich countries.

-- #DonaldTrump #DavidRicks #PascalSoriot #PeterKolchinsky #MartyMakary #DariusLakdawalla #UnitedStates #Europe #China #India #ReinoUnido #health

Loading quoted post…

Donald Trump David Ricks Pascal Soriot Peter Kolchinsky Marty Makary Darius Lakdawalla United States Europe

10/4/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdv77a3y7pwu6298see5jguc6x8ksnd84g2v5awc93hl2k6qc3yvsamz6jr

LILLY TO BUILD $6.5B HOUSTON FACTORY FOR ITS FIRST OBESITY PILL

https://s.yimg.com/ny/api/res/1.2/CATXB0uHPdESoB58WgenTQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/manufacturing_dive_692/07fa929717374d9bee4e1e35f6ab3300

✍️ Eli Lilly is building a $6.5 billion factory in Houston to manufacture its first obesity pill and other small molecule medicines, creating 615 full-time jobs.

-- #DavidRicks #Houston #GenerationPark #GoochlandCounty #Richmond #Virginia #Texas #Indiana #NorthCarolina #NewJersey #Wisconsin #PuertoRico #business

Loading quoted post…

David Ricks Houston Generation Park Goochland County Richmond Virginia Texas Indiana

9/25/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2xnd0qnu5kxehjc4q6w096a72nxz68fve8yy8y0jp6ujv9n7f06qy2ussg

ELI LILLY TO BUILD $6.5BN ORFORGLIPRON PRODUCTION SITE IN TEXAS

https://media.zenfs.com/en/pharmaceutical_technology_376/45c4320b83276a7201a9550d2ec2e593

✍️ Eli Lilly is building a $6.5 billion active pharmaceutical product (API) facility in Texas, US, to produce its small molecule therapeutics, including orforglipron, a potential treatment for obesity and type 2 diabetes.

-- #DavidRicks #DonaldTrump #Texas #Virginia #Austin #LakeHouston #GoochlandCounty #health

Loading quoted post…

David Ricks Donald Trump Texas Virginia Austin Lake Houston Goochland County health

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqlteluc608u7s807pcdnpk0fu4umt3m6fut3uvqdry5f4pxvl08rqsrxghs

LILLY TO INVEST $6.5BN IN API MANUFACTURING FACILITY IN TEXAS

https://s.yimg.com/ny/api/res/1.2/lX349uUogC6p1RQ8cAppUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/pharmaceutical_technology_376/d3106aa7614535d61874dba5b6221a17

✍️ Eli Lilly and Company plans to invest $6.5bn in an API manufacturing facility in Houston, Texas, creating 615 permanent jobs and generating 4,000 jobs during the construction phase.

-- #DavidRicks #Houston #Texas #GenerationPark #GoochlandCounty #Virginia #business

Loading quoted post…

David Ricks Houston Texas Generation Park Goochland County Virginia business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqs0futyzj3r9gy0s0w8f5kpjlk42ukf9nyqgchr2f9evc429vc97qfyn8he

ELI LILLY TO BUILD $6.5 BILLION TEXAS MANUFACTURING FACILITY FOR OBESITY PILL, OTHER DRUGS

https://image.cnbcfm.com/api/v1/image/108202857-1758645145595-Savage_Rendering.jpg?v=1758645286&w=1920&h=1080

✍️ Eli Lilly to spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of small molecule drugs, including its experimental obesity pill.

-- #DavidRicks #DonaldTrump #Houston,Texas #UnitedStates #business

Loading quoted post…

David Ricks Donald Trump Houston, Texas United States business mainstream:perspective

9/23/2025

npub17r26x6s…qehva5

ELI LILLY’S OBESITY PILL OUTPERFORMS NOVO NORDISK’S ORAL DRUG IN HEAD-TO-HEAD DIABETES TRIAL

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1758079235&w=1920&h=1080

✍️ Eli Lilly's experimental pill outperformed Novo Nordisk's oral drug in a head-to-head study for Type 2 diabetes patients, with better blood sugar control and weight loss.

-- #DanSkovronsky #HowardWeintraub #DavidRicks #JaimeAlmandoz #Indianapolis #NewYork #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzpux45d4p4xur8cxzhn5qa70dnwrgl0mu4xmsvvwy2de3hefumppfqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq55a9sdwscju0enrjuy5msqwkzuz8u07498d4h9vxt6pgnah9aqyqnjpfug

Dan Skovronsky Howard Weintraub David Ricks Jaime Almandoz Indianapolis New York health mainstream:perspective

9/17/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5z99hp3pdj5uut5z6ulzsw34s0ar3tg8qvs7h5ql3r7vlaz0dphq83anq7

ELI LILLY TO INVEST $5 BILLION IN NEW VIRGINIA PLANT AS PHARMA BRACES FOR TARIFFS

https://media.zenfs.com/en/reuters-finance.com/501f23f2f11af58b00af165222c16992

✍️ Eli Lilly to invest $5 billion in a new manufacturing facility in Virginia, expanding domestic production and hedging against potential tariffs.

-- #DavidRicks #Virginia #GoochlandCounty #business

Loading quoted post…

David Ricks Virginia Goochland County business mainstream:perspective

9/16/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjwlgn7wlvsxju94manemt6r7h6ms0p6u2gq9x6yett5f43ytqg8swr3vj3

JIM CRAMER URGES PATIENCE WITH ELI LILLY AND COMPANY (LLY)’S STOCK

https://s.yimg.com/ny/api/res/1.2/jpFqt3OWj5BLfvymCRKwqA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NDE-/https://media.zenfs.com/en/insidermonkey.com/67016191d6d2df48fd6f8c9ec632b347

✍️ Jim Cramer discusses Eli Lilly and Company's latest weight loss drug trial, praising CEO David Ricks and the company's potential.

-- #JimCramer #DavidRicks #business

Loading quoted post…

Jim Cramer David Ricks business mainstream:perspective

9/3/2025

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxd894clzhedm2ylu0m5k9jeue797jmdygajec3ne8dnm8p9jkwzs6h94k2

ELI LILLY'S OBESITY PILL REMAINS A VIABLE RIVAL TO NOVO'S ORAL WEGOVY DESPITE DATA THAT UNDERWHELMED INVESTORS

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1755834451&w=1920&h=1080

✍️ Eli Lilly's obesity pill, orforglipron, underwhelmed Wall Street with its trial data, causing less weight loss and higher side effects than expected. Despite this, analysts believe it could still be a viable competitor in the weight loss drug market.

-- #DavidRicks #Mihail'Misha'Zilbermint #MikeDoustar #EvanSeigerman #DavidRisinger #JaredHolz #Indianapolis #Copenhagen #Bagsvaerd #health

Loading quoted post…

David Ricks Mihail 'Misha' Zilbermint Mike Doustar Evan Seigerman David Risinger Jared Holz Indianapolis Copenhagen

8/24/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqnrk4gf3hsh0ps9c0hc6du3547hmq4pd0xtdh9qjhmgxq0l7vhm6qz0nmh3

NOVO NORDISK SOARS AFTER 50% OZEMPIC DISCOUNT, LIVER TREATMENT APPROVAL

https://s.yimg.com/ny/api/res/1.2/jpFHBMxg5hOUgTkB5UNRdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://media.zenfs.com/en/the_daily_upside_435/c54e2274e57e079ff0abfa24cf7e8bdb

✍️ Novo Nordisk announces a discount on its diabetes drug Ozempic for cash-paying customers in the US, priced at $499 per month, in an effort to defend its market share against competitors.

-- #DonaldTrump #DavidRicks #KansasCity #Washington #business

Loading quoted post…

Donald Trump David Ricks Kansas City Washington business mainstream:perspective

8/20/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqkaquc7s2knk8f2xu7vety2n0fv4n3gwdtlycpx6un2wxzvgdmlvsfxa4h9

LLY: ELI LILLY STOCK TANKS -- INSIDERS RUSH IN WITH MILLIONS

https://media.zenfs.com/en/us.finance.gurufocus/6ada8bac43bee8fbae1bb1b3966ea10f

✍️ Eli Lilly insiders, including CEO David Ricks and Chief Scientific Officer Dan Skovronsky, purchased shares after a 14% drop in the company's stock price due to disappointing trial results.

-- #DavidRicks #DanSkovronsky #GabrielleSulzberger #ErikFrywald #IlyaYuffa #business

Loading quoted post…

David Ricks Dan Skovronsky Gabrielle Sulzberger Erik Frywald Ilya Yuffa business mainstream:perspective

8/13/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqw4vz98pzj8xedfy0ryj5kjvvrw4kcja05l52kze4e4panq3kf4nqefgseh

WHY NOVO NORDISK STOCK FLEW HIGHER ON FRIDAY

https://s.yimg.com/ny/api/res/1.2/Qi4SdZuUKVDKJ9Xr9lj8iA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/3e0f8f08e4f3e742a6f73072a0aa4245

✍️ Novo Nordisk's stock price rose nearly 5% on Friday after Eli Lilly's investigational obesity drug, orforglipron, showed less impressive results in a clinical study compared to Novo Nordisk's Wegovy.

-- #DavidRicks #business

Loading quoted post…

8/10/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqzyp0ukjjv02ra54glpmxmz0r72k88vmm9wyynf7amh427dpq4yhqm8t24t

ELI LILLY WEIGHT-LOSS PILL TRIAL DISAPPOINTS, OFFSETTING SOLID PROFIT AND SALES

https://s.yimg.com/ny/api/res/1.2/27kZavsE_Tgojw0QZGVJzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/investopedia_245/26e590b53b7beaa8077e62e187b83ecc

✍️ Eli Lilly's experimental weight loss pill, orforglipron, showed disappointing results in a late-stage trial, with average weight loss below that of rival Novo Nordisk's Wegovy.

-- #DavidRicks #business

Loading quoted post…

8/8/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq63z42qckun7t87q8fxhlkcmzvyf4lwt0my2n4afdmlsdgwcvdapqjgcaw7

THIS BLUE-CHIP STOCK IS COOKING UP A MAJOR GROWTH CATALYST

https://s.yimg.com/ny/api/res/1.2/P2m_8PEC7iGRb8sIC7LPGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03Nzk-/https://media.zenfs.com/en/barchart_com_477/5f81f612d4b225905cde3fd6dfce2095

✍️ Eli Lilly and Company's diabetes medication, Mounjaro, has shown promising results in a landmark study, demonstrating cardiovascular benefits comparable to traditional heart medications. This breakthrough could expand Mounjaro's prescribing potential and accelerate the company's momentum.

-- #DavidRicks #JaredHolz #Dr.DavidBroome #KenCuster #health

Loading quoted post…

David Ricks Jared Holz Dr. David Broome Ken Custer health mainstream:perspective

8/7/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqpm8uejg49f5h7aq555p6g63jydl9wxls336ev24uejucx774zc2sdq5crs

THE 3 THINGS THAT MATTER FOR ELI LILLY NOW

https://s.yimg.com/ny/api/res/1.2/OjD73lQ1C5m3EiV_1z5UQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/4ec62ad0158497cb622542747ccc1bed

✍️ Eli Lilly's stock performance has been impacted by a slowdown this year, but the company's prospects remain strong, driven by its oral GLP-1 candidate tirzepatide and its pipeline of other candidates.

👉 Tirzepatide's sales growth and potential label expansions 👉 Orglipron's phase 3 results in weight management 👉 Eli Lilly's valuation and potential for a sell-off if results disappoint

-- #DavidRicks #business

Loading quoted post…

7/24/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrm2nhck7pg6dje3w5ua4d4tz873fnxcmqpm3y22slx0lyxa3svqsjtzllm

ELI LILLY AND COMPANY (LLY): I WOULD “LOVE” IF TRUMP PRAISED THE COMPANY, SAYS JIM CRAMER

https://s.yimg.com/ny/api/res/1.2/UjoPACeXPFyN.4G.yM_TTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3

✍️ Jim Cramer discusses Eli Lilly and Company (NYSE:LLY) as a potential investment opportunity, citing its lead in the weight loss drug market and pipeline of drugs targeting diseases such as hypertension.

-- #JimCramer #DavidRicks #KenLangone #RFKJr. #business

Loading quoted post…

Jim Cramer David Ricks Ken Langone RFK Jr.business mainstream:perspective

7/12/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqxny6cptfxhnc4ac6t9he35lx5q4vu6pw6xt7gpmavagvg5fn2w4qsjt5m9

ANALYSIS-NOVO NORDISK SHOULD LOOK TO THE US FOR ITS NEXT CEO, ANALYSTS SAY

https://media.zenfs.com/en/reuters-finance.com/a35c1b481cd59ba9e90b8b6e2993ec4f

✍️ Novo Nordisk is searching for a new CEO to replace Lars Fruergaard Jorgensen, and analysts suggest an American leader could be better suited to navigate the company's largest market, the US, amidst the Trump administration's changes to pharmaceutical trade, manufacturing, and regulation.

-- #LarsFruergaardJorgensen #LarsRebienSorensen #MadsOvlisen #DavidMoore #DonaldTrump #DavidRicks #EvanSeigerman #AlexAzar #Denmark #UnitedStates #London #NewYork #Indyansapolis #business

Loading quoted post…

Lars Fruergaard Jorgensen Lars Rebien Sorensen Mads Ovlisen David Moore Donald Trump David Ricks Evan Seigerman Alex Azar

5/17/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqzrdw35cedffgfztya4vh6njdkgh9ac8aekgjlny3m0ctjpr6yelsrnaqcf

DOWN NEARLY 20%: SHOULD YOU BUY THE DIP ON ELI LILLY?

https://s.yimg.com/ny/api/res/1.2/RkAifZVs2u3WF6cBAUVPQQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/d5878469cb97eb1c273d6fd5d5520396

✍️ Eli Lilly's share price has declined due to earnings misses and increased competition, but the company's growth prospects still look promising.

-- #DavidRicks #business

Loading quoted post…

5/9/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2t0qmsqejdxnzqv93e6v9t8ft4kj08mpkfd0v5gy9lv3730llqsq7uj8lz

TRUMP IS THREATENING BIG PHARMA WITH TARIFFS. TAX CHANGES MIGHT WORK BETTER.

https://s.yimg.com/ny/api/res/1.2/Ysn2ZnFwMizyKsrmwzxwfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/the_wall_street_journal_hosted_996/4f2301aba414d3f6169ce056b9c6b76c

✍️ President Trump's tariffs may not bring back industries that rely on cheap labor, but changes to the tax code could encourage long-term investment in the US.

-- #DavidRicks #ChristineKachinsky #GeorgeCallas #BradSetser #MartaWosińska #PaulRyan #DonaldTrump #Ireland #Pennsylvania #Ohio #Europe #China #India #business

Loading quoted post…

David Ricks Christine Kachinsky George Callas Brad Setser Marta Wosińska Paul Ryan Donald Trump Ireland

5/8/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqec4099u8ckx4xw6zxem8s7cm975mkpargeyvq7rrntthnugmeg3syndgmw

WITH COMPOUNDERS OUT OF THE WAY, LILLY AND NOVO GO AFTER EACH OTHER

https://s.yimg.com/ny/api/res/1.2/gt2AJjJlIUQApjs9IbltKQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/pharma_voice_330/c1ac62ef819bc147c6612404328d2b78

✍️ GLP-1 rivals Eli Lilly and Novo Nordisk are engaged in a battle for market dominance in the obesity space, with Lilly now holding a 53% share of the market.

-- #DavidRicks #PatrickJonsson #PremShah #health

Loading quoted post…

David Ricks Patrick Jonsson Prem Shah health mainstream:perspective

5/5/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqkjng2zgd3ksfrahuf9j8m9nvah8w9uxa6pwxqstarh5auyuukazs9mpe7j

WHAT IS CVS? 'WE ARE ... WORKING THROUGH THAT VERY QUESTION'

https://s.yimg.com/ny/api/res/1.2/6dtG3NDISSb.oCs8l_0qew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-05/5ea5d9c0-26bc-11f0-8f6b-dc6b742f3b22

✍️ CVS Health's CEO David Joyner is working to define the company's identity and strategy, as it faces challenges in its retail pharmacy business and questions about its ability to succeed in the health provider space.

-- #DavidJoyner #KarenLynch #DavidRicks #health

Loading quoted post…

David Joyner Karen Lynch David Ricks health mainstream:perspective

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjcvhp7tqr7hfhgf2ldxzanq67y3c25a7gu4tjg95d6ppx8cmtwpqd9x3py

ELI LILLY STOCK SELL-OFF WAS 'OVERREACTION': ANALYSTS

https://s.yimg.com/ny/api/res/1.2/rIzohBB.wriHeI88c5Mh.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-05/c68a4b50-2759-11f0-bbfe-08549428ce43

✍️ Eli Lilly's stock plummeted 12% after Novo Nordisk secured a preferred listing deal with CVS for its obesity drug Wegovy, excluding Eli Lilly's Zepbound.

-- #DavidRisinger #AkashTewari #TimAnderson #DavidRicks #AnjaleeKhemlani #business

Loading quoted post…

David Risinger Akash Tewari Tim Anderson David Ricks Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqt50pmjg60h5kpv7dq54nslxl9hu52ssqzygwrkqaqglg204l0qeq7ug4j0

LOWER TAXES COULD BRING MORE DRUG PRODUCTION TO U.S., SAYS ELI LILLY

https://images.wsj.net/im-34062673/social

✍️ Eli Lilly CEO David Ricks suggests that lower taxes could bring more drug production back to the US, citing the potential for permanent low tax rates.

-- #DavidRicks #US #business

Loading quoted post…

David Ricks US business mainstream:perspective

5/2/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvuvxcaznuf6v7d6qz3rza4d70ad9fcyspdj737ax097zfmdg3trq9jvlmt

ELI LILLY STOCK SLIPS DESPITE EARNINGS BEAT, REAFFIRMED 2025 GUIDANCE

https://s.yimg.com/ny/api/res/1.2/MwywwZOTU4FpEEiAYybdaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-04/9f779d70-25ff-11f0-b6f7-9778a735cf34

✍️ Eli Lilly reported strong first-quarter earnings, beating expectations, but GLP-1 sales were modestly ahead of consensus.

-- #DavidRicks #AnjaleeKhemlani #business

Loading quoted post…

David Ricks Anjalee Khemlani business mainstream:perspective

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvwgxaqxevgp29phvlm42ye347t3yvz3h2dp9qt8n39z7vzanw7dsyjw45l

TRUMP HINTS AT TARIFF REPRIEVE FOR PHARMA FIRMS WHO BRING OPERATIONS BACK TO US

https://i.guim.co.uk/img/media/af40329f336707b11e7c2065b035c5a14e180eec/0_257_3085_1852/master/3085.jpg?width=140&quality=85&auto=format&fit=max&s=9220b86c25c7f98a3ee4c67e3c213d7d

✍️ Donald Trump hints at a tariff reprieve for pharmaceutical companies, offering them 'a lot of time' to move operations to the US before facing import taxes.

-- #DonaldTrump #DavidRicks #JoaquinDuato #AppleCEO(notspecified) #WhiteHouse #Ireland #US #politics

Loading quoted post…

Donald Trump David Ricks Joaquin Duato Apple CEO (not specified)White House Ireland US politics

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7ucjzhtr3md45kvwtejy238mzkmf6382k9zn0lf3rlnrg8xulw2qdajtak

JIM CRAMER CALLS ELI LILLY AND COMPANY (LLY) A ‘GAME CHANGER’ AFTER OBESITY PILL TRIAL SUCCESS

https://media.zenfs.com/en/insidermonkey.com/b59e3def8f182d3e4f871bfc8cc254fe

✍️ Jim Cramer discusses the possibility of President Trump firing the chairman of the Federal Reserve, Jerome Powell, and its potential impact on the stock market.

-- #JimCramer #JeromePowell #DavidRicks #MelissaRivers #PeggyNewton #CNBC #FederalReserve #FederalTradeCommission #NorthCarolina #politics

Loading quoted post…

Jim Cramer Jerome Powell David Ricks Melissa Rivers Peggy Newton CNBC Federal Reserve Federal Trade Commission

4/25/2025

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqtg6yz7k66ylyfxfu3z3tyyta58qtlrjmwtnvkczjsyy8s66xzncsdvakxz

INTUITIVE SURGICAL DIVES. THE IMPACT FROM TARIFFS 'COULD BE MATERIAL.'

https://www.investors.com/wp-content/uploads/2019/01/stock-Intuitive-Surgical-04-shutter.jpg

✍️ Intuitive Surgical's stock plummeted after the company warned that President Trump's tariffs could have a 'material' impact on its financials this year.

-- #DonaldTrump #JoaquinDuato #DavidRicks #TravisSteed #AllisonGatlin #UnitedStates #China #Sunnyvale,California #business

Loading quoted post…

Donald Trump Joaquin Duato David Ricks Travis Steed Allison Gatlin United States China Sunnyvale, California

4/24/2025

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqm2m4sm6stkg2m7jtnqcjrszqr6rk88hwt9xkm25k4ggcy3qvmxls7rtnt2

NEW DAILY WEIGHT-LOSS PILL SHOWS SUCCESS AT CLINICAL TRIAL

https://i.guim.co.uk/img/media/305b35a980ce76ca7cc6787ec59c291cad49285f/0_111_3355_2014/master/3355.jpg?width=140&quality=85&auto=format&fit=max&s=89362cc06f17783a14374b5b227b926c

✍️ A daily weight-loss pill, orforglipron, has been found to help people shed pounds and reduce blood sugar levels, making it a contender to combat obesity and diabetes.

-- #DavidRicks #NaveedSattar #US #China #India #Japan #Mexico #Britain #Glasgow #health

Loading quoted post…

David Ricks Naveed Sattar US China India Japan Mexico Britain

nostr:nevent1qvzqqqqqqypzp8zp6yt95ahd574m8kuave0x0lwjxvsd6x5vdfjl7s9xty6ave7vqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqrfkmwhx7g3ljnm45wc2p76j9x42avf7qd2p2gqq4h7476ldxxl7quphwqd

ELI LILLY'S WEIGHT LOSS PILL SUCCEEDS IN FIRST LATE-STAGE TRIAL ON DIABETES PATIENTS

https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1744850495&w=1920&h=1080

✍️ Eli Lilly's daily obesity pill, orforglipron, met the company's goals in a late-stage trial, helping Type 2 diabetes patients lower their blood sugar and body weight, and showing safety on par with popular injections.

-- #DavidRicks #Indianapolis,Indiana #health

Loading quoted post…

David Ricks Indianapolis, Indiana health mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqjsxvqsydllrffzvj8c0auttfvhvq3q6fksv39usje70uucnwkmsq70qce5

DOW JONES, S&P 500 PHARMA NAMES RECOVER AFTER TRUMP BACKS OFF HIS TARIFFS PLAN

https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg

✍️ President Trump's announcement of major tariffs on drug imports caused a brief shock in the pharmaceutical industry, but he later delayed the tariffs for 90 days, leading to a recovery in pharma stocks.

-- #DonaldTrump #MarieThibault #DavidRisinger #DavidRicks #JohnAdent #BrandonVazquez #China #US #Europe #business

Loading quoted post…

Donald Trump Marie Thibault David Risinger David Ricks John Adent Brandon Vazquez China US

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2f00rqu28j2cu7law2l6uy0cz3ycwy6ch47q30nvxqxp4g0f2qzqxnacdl

JIM CRAMER ON ELI LILLY AND COMPANY (LLY): “YOU DON’T SELL LILLY” — “DAVID RICKS IS A VISIONARY”

https://media.zenfs.com/en/insidermonkey.com/dc5a2bcb6b4c16a43cb5b4ba98feb139

✍️ Jim Cramer discusses Eli Lilly and Company's (NYSE:LLY) performance and expresses support for the company's CEO and stock.

-- #JimCramer #JamesSurowiecki #DavidRicks #PresidentTrump #Frankfurt,Germany #business

Loading quoted post…

Jim Cramer James Surowiecki David Ricks President Trump Frankfurt, Germany business mainstream:perspective

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq673kjpn408rcryv33l0g0lkk3avgkevp268uvynecjuam6qdtn2s65hhhk

ELI LILLY CEO DAVID RICKS JUST DELIVERED TERRIBLE NEWS TO INVESTORS: SHOULD YOU SELL THE STOCK?

https://media.zenfs.com/en/motleyfool.com/561b84a0dfa536aa800055cdc5065456

✍️ Eli Lilly's CEO, David Ricks, expressed concerns about the potential impact of tariffs on the pharmaceutical industry, but the company's strong innovation and manufacturing capabilities make it a resilient investment.

-- #DavidRicks #UnitedStates #Europe #London #business

Loading quoted post…

David Ricks United States Europe London business mainstream:perspective

4/9/2025

nostr:nevent1qvzqqqqqqypzq53704dkn2v2nsehgyzexn9y92sny3j7t7yewycj0lauss6n99zuqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqdmjldkxzyu2tpcynwv36ye484d42af2779yw4mnj0z7dc4fnqmyq99dl5u

CEOS SOUND OFF ON THE RETURN-TO-OFFICE WARS: ‘I’M THE ONLY PERSON IN THE OFFICE, AND IT’S DRIVING ME NUTS’

https://s.yimg.com/ny/api/res/1.2/ETBZxnWZGC5LX7wdi9BSWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/fortune_175/86a785ad03de6a05142c0d32d8c31f38

✍️ CEOs from various industries share their strategies for attracting and retaining talent in a tight labor market, citing factors such as career opportunities, hybrid work arrangements, and upskilling.

-- #SharonMarcil #PeggyJohnson #ThierryDelaporte #DorisMeister #MariaBlack #JudyMarks #RohitKapoor #DavidRicks #JohnSchlifske #AlanMurray #U.S. #BayArea #business

Loading quoted post…

Sharon Marcil Peggy Johnson Thierry Delaporte Doris Meister Maria Black Judy Marks Rohit Kapoor David Ricks

2/3/2025

npub125q6jmq…n7fd7f

PRES. TRUMP AND RFK JR. MEET BIG PHARMA EXECUTIVES FROM PFIZER AND ELI LILLY AT MAR-A-LAGO: REPORT

https://www.thegatewaypundit.com/wp-content/uploads/2024/08/rfk-jr-kennedy-jr.-trump-e1724600494957-1200x630.jpg

✍️ Robert Kennedy Jr. endorses Donald Trump for President in 2024, citing Trump's commitment to making America healthy again and ending the chronic disease epidemic.

-- #RobertKennedyJr. #DonaldTrump #AlbertBourla #DavidRicks #SteveUbl #SusieWiles #JoeBiden #JimHoft #Mar-a-Lago #politics

Loading quoted post…

nostr:nevent1qvzqqqqqqypzq4gp49kp3rkunahg9her00mqa9zt5tpznk4wkq95cyxf0rhzcl3nqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq2q0m2g6ttsksrw2fdax72p3glwynjpxv06u9ferg6v9m7hyn5hzs42v6pw

Robert Kennedy Jr.Donald Trump Albert Bourla David Ricks Steve Ubl Susie Wiles Joe Biden Jim Hoft

12/5/2024